China to soften generic drug buying program

15 July 2019 - Chinese drug makers jumped on Monday after a local news report that a centralised drug procurement ...

Read more →

Priority review granted to BeiGene’s supplemental new drug application in China for tislelizumab in urothelial carcinoma

7 July 2019 - BeiGene today announced that the China National Medical Products Administration has granted priority review status to the ...

Read more →

China’s revolutionary cancer drugs undercut American competitors

4 June 2019 - One way to realise Beijing’s dreams of a world-class pharmaceutical industry: low prices. ...

Read more →

Chinese policies fail to curb soaring drug prices

2 June 2019 - Power of pharmaceutical monopoly starts with the manufacturing of ingredients. ...

Read more →

Improving access to high cost technologies in the Asia region

24 May 2019 - Discussions at the Health Technology Assessment International Asia Policy Forum aimed to understand the meaning of ...

Read more →

More affordable drugs offered with health care reform

25 April 2019 - China's health care reform has offered more affordable drugs for patients, said a senior health official ...

Read more →

Can cheaper drugs help home-grown labs turn the table on foreign Big Pharma in China’s cancer treatment market?

6 April 2019 - Nearly a quarter of the world’s newly diagnosed cancer cases in 2015 were in China. ...

Read more →

Novartis first-in-class Cosentyx approved in China for psoriasis patients

2 April 2019 - China Health Authority NMPA approved Cosentyx (secukinumab) for moderate-to-severe plaque psoriasis in adult patients who are ...

Read more →

VAT cut on ‘orphan drugs’ will lift healthcare burden, but many still struggle to afford medication

24 March 2019 - China has reduced value-added tax (VAT) by 3% on 21 orphan drugs and four active pharmaceutical ingredients ...

Read more →

China pledges stronger reform on approving, monitoring new drugs

23 March 2019 - China pledged to improve its system for registering new drugs in the country this year and ...

Read more →

A tiered health care delivery system for China

22 March 2019 - “China's health-care reform will be regarded as successful when a tiered health-care delivery system is fully ...

Read more →

Think drugs are expensive in the U.S.? Just try China

19 March 2019 - Beijing will want pharma companies to share the pain of the country’s growing health care costs. ...

Read more →

China moves to expand cancer medicine access

6 March 2019 - China's recent policy to increase patients' access to cancer medicines has helped more people receive quality ...

Read more →

China approves first biosimilar of foreign drug, breaking Roche monopoly

27 February 2019 - China’s National Medical Products Administration announced Monday that it has approved the country's first biosimilar drug ...

Read more →

China to establish collaboration network for rare disease diagnosis, treatment

18 February 2019 - China will establish a national collaborative network of hospitals for rare disease diagnosis and treatment to ...

Read more →